Horizon Discovery Group is an international life science company serving over 1,200 organisations engaged in bio-pharmaceutical process optimization, drug discovery and development, genomics research and molecular diagnostic development. The company provides a wide range of products and services including over 22,000 genetically-defined human disease models and derived reagents, human disease model generation services, in vitro and in vivo assay drug discovery services, and genetic and drug combination screening services.
